Mycophenolate Teva 250 Mg &Amp, 500 Mg 250 mg &, 500 mg Capsules. tablets
PDF Leaflet Revision Date: 29 March 2022
Clinical Summary
Quick overview from the medicine insert
Indication
Prophylaxis of organ rejection in transplant patients.
Dosage (summary)
Adults: 1 g twice daily for renal; 1.5 g twice daily for cardiac and hepatic transplants.
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Contraindicated in pregnancy and breastfeeding; teratogenic effects noted.
Key Drug Interactions
- Ciclosporin
- Antibiotics
- Proton pump inhibitors
- Rifampicin
Contraindications
- Hypersensitivity
- Pregnancy
- Breastfeeding
- Women not using contraception
Common side effects
- Diarrhoea
- Leucopenia
- Sepsis
- Vomiting
Counselling Points
- Use effective contraception
- Report signs of infection
- Avoid live vaccines
Serious warnings
- Increased risk of malignancies
- Opportunistic infections
- Teratogenic effects
Important Disclaimer
The Mycophenolate Teva 250 Mg &Amp, 500 Mg 250 mg &, 500 mg Capsules. tablets professional information leaflet below is the property of Teva Pharmaceuticals and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
